Home › Funds › Artia Global Partners LP › DNTH

Artia Global Partners LP position in DNTH

DIANTHUS THERAPEUTICS INC COM · Health Care

Artia Global Partners LP reported holding 162,990 shares of DNTH (DIANTHUS THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$15.9M, representing 2.93% of its reported portfolio and ranking #11 among its reported holdings. Artia Global Partners LP has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)162.99K sh
Reported value held$15.89M
Portfolio Weight2.93%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's DNTH position evolved

Artia Global Partners LP first disclosed a stake in DNTH in Q3 2025 at 108,723 shares (US$4.3M). The position peaked in Q2 2026 at 162,990 shares, worth US$15.9M. Across 4 filings, Artia Global Partners LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 162,990 shares valued at US$15.9M. Notable position changes include a 89% increase in Q4 2025 (shares rose 104% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 108.72K $4.28M New
Q4 2025 205.09K $8.45M Add
Q1 2026 162.99K $13.68M Reduce
Q2 2026 162.99K $15.89M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC COM) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has Artia Global Partners LP held DNTH?

Artia Global Partners LP has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Artia Global Partners LP's current position in DNTH?

As of Q2 2026, Artia Global Partners LP holds 162.99K shares of DNTH (DIANTHUS THERAPEUTICS INC COM), valued at $15.89M, representing 2.93% of its reported portfolio and ranking #11.

Has Artia Global Partners LP been buying or selling DNTH?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in DNTH. The position peaked in Q2 2026 at 162.99K shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.